Zobrazeno 1 - 9
of 9
pro vyhledávání: '"pathology [Mitochondrial Diseases]"'
Autor:
Daniel Erskine, David J. Koss, Johannes Attems, Viktor I. Korolchuk, Ian G. McKeith, Tiago F. Outeiro
Publikováno v:
Acta Neuropathologica
Acta neuropathologica 141(4), 511-526 (2021). doi:10.1007/s00401-021-02266-7
Acta neuropathologica 141(4), 511-526 (2021). doi:10.1007/s00401-021-02266-7
Accumulation of the protein α-synuclein into insoluble intracellular deposits termed Lewy bodies (LBs) is the characteristic neuropathological feature of LB diseases, such as Parkinson’s disease (PD), Parkinson’s disease dementia (PDD) and demen
Publikováno v:
Journal of neurochemistry 147(3), 291-309 (2018). doi:10.1111/jnc.14471
In the last decades, lysosomes and mitochondria were considered distinct and physically separated organelles involved in different cellular functions. While lysosomes were thought to exclusively be the rubbish dump of the cell involved in the degrada
Autor:
Patrick Krumm, Andreas Oettinger, Marius Horger, Adam P. Vogel, Matthis Synofzik, Natalie Rommel, Eva-Maria Kraus, Ludger Schöls
Publikováno v:
Mitochondrion 37, 1-7 (2017). doi:10.1016/j.mito.2017.06.002
Background Mutations in the nuclear-encoded mitochondrial DNA polymerase gamma (POLG) can result in a wide spectrum of neurological deficits. A common presentation is progressive ataxia (POLG-A) which includes impaired speech and swallowing. The natu
Autor:
Fabio Bertan, Jonas Schroer, Antonia Piazzesi, Lena Wischhof, Anna Gioran, Pierluigi Nicotera, Daniele Bano
Publikováno v:
The EMBO Journal
The EMBO journal 38(6), e99558 (2019). doi:10.15252/embj.201899558
The EMBO journal 38(6), e99558 (2019). doi:10.15252/embj.201899558
Aberrant mitochondrial function contributes to the pathogenesis of various metabolic and chronic disorders. Inhibition of insulin/IGF‐1 signaling (IIS) represents a promising avenue for the treatment of mitochondrial diseases, although many of the
Autor:
Repp, Birgit M., Mastantuono, Elisa, Alston, Charlotte L., Schiff, Manuel, Haack, Tobias B., Rotig, Agnes, Ardissone, Anna, Lombes, Anne, Catarino, Claudia B., Diodato, Daria, Schottmann, Gudrun, Poulton, Joanna, Burlina, Alberto, Jonckheere, An, Munnich, Arnold, Rolinski, Boris, Ghezzi, Daniele, Rokicki, Dariusz, Wellesley, Diana, Martinelli, Diego, Ding, Wenhong, Lamantea, Eleonora, Ostergaard, Elsebet, Pronicka, Ewa, Pierre, Germaine, Smeets, Hubert J. M., Wittig, Ilka, Scurr, Ingrid, de Coo, Irenaeus F. M., Moroni, Isabella, Smet, Joel, Mayr, Johannes A., Dai, Lifang, de Meirleir, Linda, Schuelke, Markus, Zeviani, Massimo, Morscher, Raphael J., McFarland, Robert, Seneca, Sara, Klopstock, Thomas, Meitinger, Thomas, Wieland, Thomas, Strom, Tim M., Herberg, Ulrike, Ahting, Uwe, Sperl, Wolfgang, Nassogne, Marie-Cecile, Ling, Han, Fang, Fang, Freisinger, Peter, Van Coster, Rudy, Strecker, Valentina, Taylor, Robert W., Haberle, Johannes, Vockley, Jerry, Prokisch, Holger, Wortmann, Saskia
Publikováno v:
Orphanet Journal of Rare Diseases
Orphanet journal of rare diseases 13(1), 120 (2018). doi:10.1186/s13023-018-0784-8
Orphanet Journal of Rare Diseases, Vol. 13, no. 1, p. 120 [1-10] (2018)
Orphanet journal of rare diseases
Repp, B M, Mastantuono, E, Alston, C L, Schiff, M, Haack, T B, Rötig, A, Ardissone, A, Lombès, A, Catarino, C B, Diodato, D, Schottmann, G, Poulton, J, Burlina, A, Jonckheere, A, Munnich, A, Rolinski, B, Ghezzi, D, Rokicki, D, Wellesley, D, Martinelli, D, Wenhong, D, Lamantea, E, Ostergaard, E, Pronicka, E, Pierre, G, Smeets, H J M, Wittig, I, Scurr, I, de Coo, I F M, Moroni, I, Smet, J, Mayr, J A, Dai, L, de Meirleir, L, Schuelke, M, Zeviani, M, Morscher, R J, McFarland, R, Seneca, S, Klopstock, T, Meitinger, T, Wieland, T, Strom, T M, Herberg, U, Ahting, U, Sperl, W, Nassogne, M-C, Ling, H, Fang, F, Freisinger, P, Van Coster, R, Strecker, V, Taylor, R W, Häberle, J, Vockley, J, Prokisch, H & Wortmann, S 2018, ' Clinical, biochemical and genetic spectrum of 70 patients with ACAD9 deficiency : is riboflavin supplementation effective? ', Orphanet Journal of Rare Diseases, vol. 13, 120 . https://doi.org/10.1186/s13023-018-0784-8
ORPHANET JOURNAL OF RARE DISEASES
Orphanet Journal of Rare Diseases, 13:120. BioMed Central Ltd.
Orphanet Journal of Rare Diseases, Vol 13, Iss 1, Pp 1-10 (2018)
Orphanet J. Rare Dis. 13:120 (2018)
Orphanet Journal of Rare Diseases, 13:120. BioMed Central Ltd
Orphanet journal of rare diseases 13(1), 120 (2018). doi:10.1186/s13023-018-0784-8
Orphanet Journal of Rare Diseases, Vol. 13, no. 1, p. 120 [1-10] (2018)
Orphanet journal of rare diseases
Repp, B M, Mastantuono, E, Alston, C L, Schiff, M, Haack, T B, Rötig, A, Ardissone, A, Lombès, A, Catarino, C B, Diodato, D, Schottmann, G, Poulton, J, Burlina, A, Jonckheere, A, Munnich, A, Rolinski, B, Ghezzi, D, Rokicki, D, Wellesley, D, Martinelli, D, Wenhong, D, Lamantea, E, Ostergaard, E, Pronicka, E, Pierre, G, Smeets, H J M, Wittig, I, Scurr, I, de Coo, I F M, Moroni, I, Smet, J, Mayr, J A, Dai, L, de Meirleir, L, Schuelke, M, Zeviani, M, Morscher, R J, McFarland, R, Seneca, S, Klopstock, T, Meitinger, T, Wieland, T, Strom, T M, Herberg, U, Ahting, U, Sperl, W, Nassogne, M-C, Ling, H, Fang, F, Freisinger, P, Van Coster, R, Strecker, V, Taylor, R W, Häberle, J, Vockley, J, Prokisch, H & Wortmann, S 2018, ' Clinical, biochemical and genetic spectrum of 70 patients with ACAD9 deficiency : is riboflavin supplementation effective? ', Orphanet Journal of Rare Diseases, vol. 13, 120 . https://doi.org/10.1186/s13023-018-0784-8
ORPHANET JOURNAL OF RARE DISEASES
Orphanet Journal of Rare Diseases, 13:120. BioMed Central Ltd.
Orphanet Journal of Rare Diseases, Vol 13, Iss 1, Pp 1-10 (2018)
Orphanet J. Rare Dis. 13:120 (2018)
Orphanet Journal of Rare Diseases, 13:120. BioMed Central Ltd
Background Mitochondrial acyl-CoA dehydrogenase family member 9 (ACAD9) is essential for the assembly of mitochondrial respiratory chain complex I. Disease causing biallelic variants in ACAD9 have been reported in individuals presenting with lactic a
Autor:
Sarunas Augustis, Peter Schneiderat, Rita Horvath, Angela Abicht, Thomas Klopstock, Bertold Schrank, Elke Holinski-Feder, Benedikt Schoser
Publikováno v:
Neuromuscular disorders 27(5), 473-476 (2017). doi:10.1016/j.nmd.2017.02.005
We report a 36-year-old female having lifetime exercise intolerance and lactic acidosis with nausea associated with novel compound heterozygous Acyl-CoA dehydrogenase 9 gene (ACAD9) mutations (p.Ala390Thr and p.Arg518Cys). ACAD9 is an assembly factor
Autor:
Ilse Dirks, Robert McFarland, Mirian C. H. Janssen, Saskia Koene, Cheuk-Wing Fung, Lonneke de Boer, Jan A.M. Smeitink, Elizabeth M. McCormick, Imelda J. M. de Groot, Claudia Stendel, Thomas Klopstock, I. René F. M. de Coo, Izelle Smuts, Katharina Vill, Virginia Wong, Marni J. Falk, Jan C.M. Hendriks, Maaike de Vries
Publikováno v:
Journal of Inherited Metabolic Disease, 39(5), 705-712. Springer Netherlands
Journal of inherited metabolic disease 39(5), 705-712 (2016). doi:10.1007/s10545-016-9948-7
Journal of Inherited Metabolic Disease, 39, 705-12
Journal of Inherited Metabolic Disease, 39, 5, pp. 705-12
Journal of inherited metabolic disease 39(5), 705-712 (2016). doi:10.1007/s10545-016-9948-7
Journal of Inherited Metabolic Disease, 39, 705-12
Journal of Inherited Metabolic Disease, 39, 5, pp. 705-12
Contains fulltext : 167896.pdf (Publisher’s version ) (Open Access) OBJECTIVE: There is an urgent need for reliable and universally applicable outcome measures for children with mitochondrial diseases. In this study, we aimed to adapt the currently
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::96db96155290218d357cd94a7b4981bd
https://pure.eur.nl/en/publications/38dad62b-a27d-41cf-bb9f-16940544cae9
https://pure.eur.nl/en/publications/38dad62b-a27d-41cf-bb9f-16940544cae9
Publikováno v:
Genome medicine 8(1), 126 (2016). doi:10.1186/s13073-016-0380-2
Genome Medicine
Genome Med. 8:126 (2016)
Genome Medicine, Vol 8, Iss 1, Pp 1-3 (2016)
Genome Medicine
Genome Med. 8:126 (2016)
Genome Medicine, Vol 8, Iss 1, Pp 1-3 (2016)
Editorial summary The advent of mitochondrial replacement techniques poses many scientific, regulatory, and ethical questions. Previous studies suggest good safety and efficacy profiles of these techniques, but challenges remain for clinical implemen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::63a05c627278cd822a0266fadc21a6c2
Publikováno v:
European Journal of Human Genetics
European Journal of Human Genetics; Vol 19
Zaragoza, Michael V; Brandon, Martin C; Diegoli, Marta; Arbustini, Eloisa; & Wallace, Douglas C. (2011). Mitochondrial cardiomyopathies: how to identify candidate pathogenic mutations by mitochondrial DNA sequencing, MITOMASTER and phylogeny.. European journal of human genetics : EJHG, 19(2), 200-207. UC Irvine: Institute for Clinical and Translational Science. Retrieved from: http://www.escholarship.org/uc/item/4sm8732p
Zaragoza, MV; Brandon, MC; Diegoli, M; Arbustini, E; & Wallace, DC. (2011). Mitochondrial cardiomyopathies: How to identify candidate pathogenic mutations by mitochondrial DNA sequencing, MITOMASTER and phylogeny. European Journal of Human Genetics, 19(2), 200-207. doi: 10.1038/ejhg.2010.169. UC Irvine: Retrieved from: http://www.escholarship.org/uc/item/69920992
European Journal of Human Genetics; Vol 19
Zaragoza, Michael V; Brandon, Martin C; Diegoli, Marta; Arbustini, Eloisa; & Wallace, Douglas C. (2011). Mitochondrial cardiomyopathies: how to identify candidate pathogenic mutations by mitochondrial DNA sequencing, MITOMASTER and phylogeny.. European journal of human genetics : EJHG, 19(2), 200-207. UC Irvine: Institute for Clinical and Translational Science. Retrieved from: http://www.escholarship.org/uc/item/4sm8732p
Zaragoza, MV; Brandon, MC; Diegoli, M; Arbustini, E; & Wallace, DC. (2011). Mitochondrial cardiomyopathies: How to identify candidate pathogenic mutations by mitochondrial DNA sequencing, MITOMASTER and phylogeny. European Journal of Human Genetics, 19(2), 200-207. doi: 10.1038/ejhg.2010.169. UC Irvine: Retrieved from: http://www.escholarship.org/uc/item/69920992
Pathogenic mitochondrial DNA (mtDNA) mutations leading to mitochondrial dysfunction can cause cardiomyopathy and heart failure. Owing to a high mutation rate, mtDNA defects may occur at any nucleotide in its 16 569 bp sequence. Complete mtDNA sequenc